Table 1 Summary of reported case records and retrospective/prospective studies

Gottenberg et al. [17]

Lymph nodes

4 × 375 mg/m²

Good

Belkhou et al. [15]

Lymph nodes

2 × 1 g, every 2 weeks

Good

Dasilva et al. [13]

Lymph nodes, including peritoneal

Two infusions, dose not specified

Good

Bomprezzi et al. [11]

CNS and skin

2 × 1 g, every 2 weeks, then 1 g every 6 months for 2 years

Good

Lower et al. [14]

Eye; 2 of 4 patients also had significant lung involvement

2 × 1 g, every 2 weeks, then 375 mg/m² every 4 or 8 weeks for a minimum of 24 months or 1 g every 4 weeks for 10 months

Three responders of four patients

Sawaya et al. [12]

Neuromyelitis optica and lymph nodes

Single 1 g infusion

Good

Sweiss et al. [16]

Lung

2 × 1 g, every 2 weeks

Seven full or partial responders of ten patients